Five Questions For Boehringer Ingelheim's Data Boss
This article was originally published in Scrip
The end of 2015 saw Boehringer Ingelheim follow a number of its pharmaceutical peers by bringing in an external service provider – in this case Medidata Solutions – to meet its cloud technology and data analysis needs. Scrip spoke with Klaus Stern, global head of biostatistics and data sciences at Boehringer, to find out why fortifying the company's internal R&D efforts with external cutting-edge technology was so vital.
Register for our free email digests: